Assoc. for Accessible Medicines v. Becerra

District Court, E.D. California·Decided March 23, 2023·No. 2:20-cv-01708·Unknown

Opinion

1 IN THE UNITED STATES DISTRICT COURT

2 FOR THE EASTERN DISTRICT OF CALIFORNIA

4 ASSOCIATION FOR ACCESSIBLE

5 MEDICINES, No. 2:20-cv-1708 TLN DB

6 Plaintiff, STIPULATION AND PROTECTIVE

7 v. ORDER 8 ROB BONTA, IN HIS OFFICIAL

9 CAPACITY AS ATTORNEY GENERAL OF

10 THE STATE OF CALIFORNIA,

11 Defendant. 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 1 Plaintiff Association for Accessible Medicines (“AAM”) and Defendant Rob Bonta, in his

2 official capacity as the Attorney General of California (“AG”) (hereinafter collectively the “Parties”

3 or individually a “Party”) anticipate that documents and information containing or reflecting

4 proprietary, trade secret, and/or commercially sensitive information may be disclosed or produced

5 during the course of discovery and otherwise in the above-captioned action (the “Action”). The

6 Parties, by and through their respective undersigned counsel, hereby stipulate to and request the

7 entry of the following Protective Order setting forth the conditions for treating, obtaining, and using

8 such information.

9 Pursuant to Rule 26(c) of the Federal Rules of Civil Procedure, the Court finds good cause

10 for the following Joint Stipulated Protective and Confidentiality Order (the “Stipulation and

11 Protective Order”).

12 1. Confidentiality of Materials 13 (a) The Parties agree that “Confidential Information” means any information, whether 14 oral, in documentary, or other tangible form, so designated by either Party (and any non-Party) that 15 the Party or non-Party reasonably and in good faith believes contains confidential commercial 16 information, proprietary financial information, trade secrets, or any other type of information 17 protectable under Fed. R. Civ. P. 26, or any other applicable state, federal or regulatory doctrine 18 and which is designated as “CONFIDENTIAL” OR “HIGHLY CONFIDENTIAL – 19 ATTORNEYS’ EYES ONLY.” 20 (b) Any information supplied in documentary or other tangible form may be designated 21 as Confidential Information by placing or affixing on such documents, or on the face of such thing, 22 the legend “CONFIDENTIAL” or “HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY.” 23 (c) Any information designated as “CONFIDENTIAL” may be disclosed only to (i) the 24 Parties; (ii) the law firm of counsel of record for Plaintiff in this Action; (iii) attorneys, officials, 25 investigators, paralegals, legal interns, and stenographic and clerical workers employed by the 26 Healthcare Rights and Access Section of Defendant who are actively working on this Action and 27 who need to access the produced documents for the purposes of this Action; (iv) managers, 28 supervisors, and officials to whom the personnel described in subpoint (c)(iii) above report and 1 who need to access the documents as part of their managerial or supervisory duties relevant to this

2 Action; or (v) any other person with prior written consent of the producing Party.

3 (d) Any information designated as “HIGHLY CONFIDENTIAL – ATTORNEYS’

4 EYES ONLY” may be disclosed only to: (i) the law firm of counsel of record for Plaintiff in this

5 Action; (ii) attorneys, officials, investigators, paralegals, legal interns, and stenographic and clerical

6 workers employed by the Healthcare Rights and Access Section of Defendant who are actively

7 working on this Action and who need to access the produced documents for the purposes of this

8 Action; (iii) managers, supervisors, and officials to whom the personnel described in subpoint

9 (d)(ii) above report and who need to access the documents as part of their managerial or supervisory

10 duties relevant to this Action; (iv) any other person with prior written consent of the producing

11 Party.

12 (e) The Parties and their counsel of record may disclose and permit the disclosure of 13 Confidential Information to the following third parties: (i) the Court; (ii) Court reporters engaged 14 for depositions and hearings; and (iii) jurors and Court personnel at trial of the Action. 15 (f) Absent a specific order by this Court, all information or documents disclosed in the 16 Action and designated as either CONFIDENTIAL or HIGHLY CONFIDENTIAL under this 17 Stipulation and Protective Order shall be used by the receiving Party solely for the purposes of the 18 Action and not in connection with any other litigation or judicial or regulatory proceeding or for 19 any business, commercial, competitive, personal, or other purpose. Confidential Information shall 20 not be disclosed to any governmental entity, including the Federal Trade Commission, without 21 prior written consent of the producing Party or non-Party. The Parties agree not to use any 22 Confidential Information to seek disclosure in any other proceeding. 23 (g) If Confidential Information in the possession, custody, or control of any receiving 24 Party is sought by a subpoena, civil investigative demand, request for production of documents, 25 interrogatories, or any other compulsory process whether issuing from any court, administrative or 26 legislative body, or any other person, agency, or tribunal purporting to have opportunity to seek 27 such information by compulsory process, the receiving Party to whom the process or discovery is 28 directed shall: (i) give notice by email together with a copy thereof to counsel of record for the 1 producing Party or non-Party promptly, and in no event fewer than five (5) business days prior to

2 the deadline for producing or objecting to production of such Confidential Information; (ii)

3 cooperate to the extent reasonably necessary to permit the producing Party or non-Party to object

4 to or seek to quash such process or discovery request; and (iii) if the producing Party or non-Party

5 makes a timely objection or seeks a protective order in the relevant action, the receiving Party shall

6 not produce any Confidential Information until a court rules on the objection and/or request for a

7 protective order (or until the producing Party consents in writing to the production).

8 2. Protection of Confidential Information. The Parties shall ensure that access to

9 Confidential Information provided to them pursuant to this Stipulation and Protective Order is

10 strictly limited as prescribed herein. The Parties shall ensure that Confidential Information is used

11 only as provided in this Stipulation and Protective Order, and that such Confidential Information is

12 not duplicated except to the extent necessary for use as permitted by this Stipulation and Protective 13 Order (with appropriate security measures taken to ensure that any such copies are maintained in a 14 confidential manner). Counsel for each Party shall take reasonable measures to limit unauthorized 15 disclosure of any designated Confidential Information. Each Party shall have the responsibility, 16 through counsel, to promptly advise the producing Party or non-Party of any losses or compromises 17 of the confidentiality of the Confidential Information. 18 3. Filings. A Party that seeks to file anything that is designated as Confidential 19 Information shall seek to file it under seal in compliance with the requirements of the Local Rules 20 of this Court. Courtesy copies of such documents shall also be redacted and shall not contain any 21 reference to the contents of the Confidential Information unless requested by the Court.

Free access — add to your briefcase to read the full text and ask questions with AI

Assoc. for Accessible Medicines v. Becerra, (E.D. Cal. 2023).

Assoc. for Accessible Medicines v. Becerra (Assoc. for Accessible Medicines v. Becerra) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Kamakana v. City and County of Honolulu
447 F.3d 1172 (Ninth Circuit, 2006)
Center for Auto Safety v. Chrysler Group, LLC
809 F.3d 1092 (Ninth Circuit, 2016)